Auro Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Auro Laboratories has a total shareholder equity of ₹370.1M and total debt of ₹153.4M, which brings its debt-to-equity ratio to 41.5%. Its total assets and total liabilities are ₹617.1M and ₹246.9M respectively. Auro Laboratories's EBIT is ₹95.0M making its interest coverage ratio 9.5. It has cash and short-term investments of ₹69.8M.
Key information
41.5%
Debt to equity ratio
₹153.44m
Debt
Interest coverage ratio | 9.5x |
Cash | ₹69.77m |
Equity | ₹370.12m |
Total liabilities | ₹246.94m |
Total assets | ₹617.06m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 530233's short term assets (₹357.2M) exceed its short term liabilities (₹139.7M).
Long Term Liabilities: 530233's short term assets (₹357.2M) exceed its long term liabilities (₹107.3M).
Debt to Equity History and Analysis
Debt Level: 530233's net debt to equity ratio (22.6%) is considered satisfactory.
Reducing Debt: 530233's debt to equity ratio has reduced from 57.5% to 41.5% over the past 5 years.
Debt Coverage: 530233's debt is well covered by operating cash flow (47.7%).
Interest Coverage: 530233's interest payments on its debt are well covered by EBIT (9.5x coverage).